ESTABLISHMENT LABS HOLDINGS
ESTANASDAQTrading Snapshot
- Day Range
- $63.24 β $64.89
- 52-Week Range
- $38.38 β $97.59
- Volume
- $2.12B
- Avg Volume
- $2.70B
- Shares Outstanding
- 29.4M
- Next Earnings
- Nov 26, 2026
Fundamentals Snapshot
- Annual Revenue
- $211M
- Last Q Revenue
- $68M
- P/E Ratio
- -48.7
- P/S Ratio
- 7.6x
- EPS (TTM)
- $-1.29
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +2.3%
Why Investors Own ESTA
- βHigh-growth profile β revenue up +13.2% YoY with expanding US Equity exposure.
- βHealthy economics β 28% gross margin and 28% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ESTABLISHMENT LABS HOLDINGS
ESTAAbout ESTABLISHMENT LABS HOLDINGS
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
ESTABLISHMENT LABS HOLDINGS tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift ESTA price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
ESTABLISHMENT LABS HOLDINGS announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.